Sale!

CD19 Gene Immunodeficiency common variable type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test is a specialized diagnostic tool designed to identify mutations in the CD19 gene, which are associated with Common Variable Immunodeficiency Type 3 (CVID3). This condition is a primary immunodeficiency disorder characterized by a reduced ability to produce antibodies, leading to an increased susceptibility to infections. The CD19 gene plays a crucial role in the development and function of B cells, which are essential for the adaptive immune response.

Performed at DNA Labs UAE, this test is vital for individuals who exhibit symptoms of immune deficiency, such as recurrent infections, particularly in the respiratory and gastrointestinal tracts. Early and accurate diagnosis through this genetic test can significantly aid in the management and treatment of the condition, improving the quality of life for affected individuals.

The cost of the CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test is 4400 AED. This investment covers the sophisticated genetic analysis required to detect the presence of mutations in the CD19 gene. Given the complexity and the specialized nature of this test, it represents a critical step towards personalized medicine for patients with symptoms suggestive of CVID3, offering them a pathway to targeted treatments and interventions.

Description

CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test

Test Name: CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test

Components: CD19 Gene Immunodeficiency Common Variable Type 3 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CD19 Gene Immunodeficiency Common Variable Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD19 Gene Immunodeficiency Common Variable Type 3 NGS Genetic DNA Test gene CD19

Test Details: CD19 gene immunodeficiency, also known as common variable immunodeficiency type 3 (CVID3), is a rare genetic disorder characterized by a deficiency in CD19 protein expression on B cells. This leads to impaired B cell function and reduced antibody production, resulting in recurrent infections, particularly of the respiratory tract. Next-generation sequencing (NGS) genetic testing is a powerful tool used to identify genetic variations or mutations in a person’s DNA. In the case of CD19 gene immunodeficiency, NGS genetic testing can be used to detect mutations or variations in the CD19 gene that may be responsible for the immunodeficiency. NGS genetic testing involves sequencing the DNA of an individual and comparing it to a reference genome to identify any genetic variations. This can help diagnose CD19 gene immunodeficiency and provide valuable information for genetic counseling and management of the condition. It is important to note that NGS genetic testing for CD19 gene immunodeficiency is typically performed in specialized laboratories and may require a physician’s referral. Genetic counseling is also recommended before and after the testing process to understand the implications of the results and provide appropriate guidance and support.

Test Name	CD19 Gene Immunodeficiency common variable type 3 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CD19 Gene Immunodeficiency common variable type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD19 Gene Immunodeficiency common variable type 3 NGS Genetic DNA Test gene CD19
Test Details	CD19 gene immunodeficiency, also known as common variable immunodeficiency type 3 (CVID3), is a rare genetic disorder characterized by a deficiency in CD19 protein expression on B cells. This leads to impaired B cell function and reduced antibody production, resulting in recurrent infections, particularly of the respiratory tract. Next-generation sequencing (NGS) genetic testing is a powerful tool used to identify genetic variations or mutations in a person’s DNA. In the case of CD19 gene immunodeficiency, NGS genetic testing can be used to detect mutations or variations in the CD19 gene that may be responsible for the immunodeficiency. NGS genetic testing involves sequencing the DNA of an individual and comparing it to a reference genome to identify any genetic variations. This can help diagnose CD19 gene immunodeficiency and provide valuable information for genetic counseling and management of the condition. It is important to note that NGS genetic testing for CD19 gene immunodeficiency is typically performed in specialized laboratories and may require a physician’s referral. Genetic counseling is also recommended before and after the testing process to understand the implications of the results and provide appropriate guidance and support.